Stephen W. Webster's most recent trade in Nextcure Inc was a trade of 2,340 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 18, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nextcure Inc | Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2026 | 2,340 | 2,340 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2026 | 25,319 | 25,319 | - | - | Stock Option (Right to Buy) | |
| Nextcure Inc | Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 18,700 | 18,700 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 38,513 | 38,513 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Stephen W. Webster | Director | Other type of transaction at price $ 0.00 per share. | 04 Apr 2025 | 103,600 | 0 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Stephen W. Webster | Director | Other type of transaction at price $ 0.00 per share. | 04 Apr 2025 | 25,000 | 0 (0%) | 0% | 0 | Common Stock | |
| Gritstone Bio Inc | Stephen W. Webster | Director | Other type of transaction at price $ 0.00 per share. | 04 Apr 2025 | 7,379 | 0 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 15,806 | 15,806 | - | - | Stock Option (Right to Buy) | |
| Nextcure Inc | Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 18,700 | 18,700 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 7,379 | 7,379 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 103,600 | 103,600 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,450 | 18,450 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 16,475 | 16,475 | - | - | Stock Option (Right to Buy) |